Literature DB >> 10665762

Low-grade astrocytoma--a retrospective analysis of 102 patients.

A Kandil1, Y Khafaga, G ElHusseiny, A Allam, A Jamshed, H Schultz.   

Abstract

One hundred and two patients (57 males, 45 females, median age 17 years) with histologically proven low-grade astrocytoma (grades I, II) treated between 1978 and 1994 were retrospectively analyzed at the King Faisal Specialist Hospital & Research Center. Microscopic investigation showed 50 patients (48%) with grade I tumors as opposed to 52 patients (52%) with grade II tumors. Fifteen patients (15%) had complete surgical excision, 55 (52%) had partial excision and 32 (31%) had biopsy only; 68 patients (66%) received external radiotherapy with a median dose of 54 Gy (range 45-68.5 Gy). With a median follow-up of 3.3 years, the 5 and 10 years, overall actuarial survival rates were 78% and 62%, respectively while the progression-free survival rates at 5 and 10 years were 69%, and 35%, respectively. Age and performance status were significant prognostic factors in terms of overall survival on univariate (p = 0.05 and 0.05, respectively) and multivariate analysis (p = 0.005 and 0.006, respectively).

Entities:  

Mesh:

Year:  1999        PMID: 10665762     DOI: 10.1080/028418699432356

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  7 in total

Review 1.  Pediatric low-grade gliomas.

Authors:  Angela J Sievert; Michael J Fisher
Journal:  J Child Neurol       Date:  2009-11       Impact factor: 1.987

2.  Treatment of low-grade diffuse astrocytomas by surgery and human fibroblast interferon without radiation therapy.

Authors:  Takao Watanabe; Yoichi Katayama; Atsuo Yoshino; Chiaki Komine; Takakazu Yokoyama; Takao Fukushima
Journal:  J Neurooncol       Date:  2003-01       Impact factor: 4.130

3.  Survival and long-term health and cognitive outcomes after low-grade glioma.

Authors:  Gregory T Armstrong; Heather M Conklin; Sujuan Huang; Deokumar Srivastava; Robert Sanford; David W Ellison; Thomas E Merchant; Melissa M Hudson; Mary Ellen Hoehn; Leslie L Robison; Amar Gajjar; E Brannon Morris
Journal:  Neuro Oncol       Date:  2010-12-22       Impact factor: 12.300

4.  The role of up-front radiation therapy for incompletely resected pediatric WHO grade II low-grade gliomas.

Authors:  Kavita K Mishra; Dev R Puri; Brian T Missett; Kathleen R Lamborn; Michael D Prados; Mitchel S Berger; Anuradha Banerjee; Nalin Gupta; William M Wara; Daphne A Haas-Kogan
Journal:  Neuro Oncol       Date:  2006-02-22       Impact factor: 12.300

Review 5.  [Perfusion measurement using the T2* contrast media dynamics in neuro-oncology. Physical basics and clinical applications].

Authors:  M-A Weber; F Risse; F L Giesel; L R Schad; H-U Kauczor; M Essig
Journal:  Radiologe       Date:  2005-07       Impact factor: 0.635

Review 6.  The role of radiotherapy in the management of patients with diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.

Authors:  Timothy C Ryken; Ian Parney; John Buatti; Steven N Kalkanis; Jeffrey J Olson
Journal:  J Neurooncol       Date:  2015-11-03       Impact factor: 4.130

Review 7.  The 2021 WHO Classification of Tumors of the Central Nervous System: An update on pediatric low-grade gliomas and glioneuronal tumors.

Authors:  Tejus A Bale; Marc K Rosenblum
Journal:  Brain Pathol       Date:  2022-02-25       Impact factor: 7.611

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.